Free Trial
→ Iran's New Leader Just Said Something That Should Terrify Every American (From American Alternative) (Ad)tc pixel Free MBX Stock Alerts

Microbix Biosystems (MBX) Competitors

Microbix Biosystems logo
C$0.25 -0.01 (-1.96%)
As of 02:27 PM Eastern
Compare

MBX vs. SCYB, COM, NVH, IGX, and PDP

Should you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), and Pediapharm (PDP). These companies are all part of the "biotechnology" industry.

How does Microbix Biosystems compare to Scythian Biosciences?

Microbix Biosystems (TSE:MBX) and Scythian Biosciences (CVE:SCYB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled Scythian Biosciences'average media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
Scythian Biosciences Neutral

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Microbix Biosystems has higher revenue and earnings than Scythian Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$16.76M2.07C$3.39M-C$0.03N/A
Scythian BiosciencesN/AN/AN/AN/AN/A

Scythian Biosciences has a net margin of 0.00% compared to Microbix Biosystems' net margin of -25.48%. Scythian Biosciences' return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-25.48% -14.88% 3.82%
Scythian Biosciences N/A N/A N/A

Summary

Microbix Biosystems beats Scythian Biosciences on 4 of the 6 factors compared between the two stocks.

How does Microbix Biosystems compare to 138267 (COM.TO)?

138267 (COM.TO) (TSE:COM) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment.

138267 (COM.TO) has a net margin of 0.00% compared to Microbix Biosystems' net margin of -25.48%. 138267 (COM.TO)'s return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
138267 (COM.TO)N/A N/A N/A
Microbix Biosystems -25.48%-14.88%3.82%

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Microbix Biosystems has higher revenue and earnings than 138267 (COM.TO).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
Microbix BiosystemsC$16.76M2.07C$3.39M-C$0.03N/A

In the previous week, 138267 (COM.TO)'s average media sentiment score of 0.00 equaled Microbix Biosystems'average media sentiment score.

Company Overall Sentiment
138267 (COM.TO) Neutral
Microbix Biosystems Neutral

Summary

Microbix Biosystems beats 138267 (COM.TO) on 4 of the 6 factors compared between the two stocks.

How does Microbix Biosystems compare to Novoheart?

Microbix Biosystems (TSE:MBX) and Novoheart (CVE:NVH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Novoheart has a net margin of 0.00% compared to Microbix Biosystems' net margin of -25.48%. Novoheart's return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-25.48% -14.88% 3.82%
Novoheart N/A N/A N/A

Microbix Biosystems has higher revenue and earnings than Novoheart. Novoheart is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$16.76M2.07C$3.39M-C$0.03N/A
NovoheartC$423.50K236.08-C$7.17M-C$0.04N/A

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled Novoheart'saverage media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
Novoheart Neutral

Summary

Microbix Biosystems beats Novoheart on 7 of the 10 factors compared between the two stocks.

How does Microbix Biosystems compare to IntelGenx Technologies?

Microbix Biosystems (TSE:MBX) and IntelGenx Technologies (CVE:IGX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Microbix Biosystems has higher revenue and earnings than IntelGenx Technologies. Microbix Biosystems is trading at a lower price-to-earnings ratio than IntelGenx Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$16.76M2.07C$3.39M-C$0.03N/A
IntelGenx TechnologiesC$1.75M49.95-C$11.74M-C$0.08N/A

IntelGenx Technologies has a net margin of 0.00% compared to Microbix Biosystems' net margin of -25.48%. IntelGenx Technologies' return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-25.48% -14.88% 3.82%
IntelGenx Technologies N/A N/A N/A

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled IntelGenx Technologies'average media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
IntelGenx Technologies Neutral

Summary

Microbix Biosystems beats IntelGenx Technologies on 6 of the 10 factors compared between the two stocks.

How does Microbix Biosystems compare to Pediapharm?

Microbix Biosystems (TSE:MBX) and Pediapharm (CVE:PDP) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Microbix Biosystems has higher revenue and earnings than Pediapharm. Microbix Biosystems is trading at a lower price-to-earnings ratio than Pediapharm, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$16.76M2.07C$3.39M-C$0.03N/A
PediapharmC$11.16M5.95-C$16.15M-C$0.07N/A

Pediapharm has a net margin of 0.00% compared to Microbix Biosystems' net margin of -25.48%. Pediapharm's return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-25.48% -14.88% 3.82%
Pediapharm N/A N/A N/A

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled Pediapharm'saverage media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
Pediapharm Neutral

Summary

Microbix Biosystems beats Pediapharm on 6 of the 10 factors compared between the two stocks.

Get Microbix Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBX vs. The Competition

Export
MetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$34.64MC$448.53MC$6.25BC$11.72B
Dividend Yield2.30%3.86%2.73%6.22%
P/E Ratio-8.334.1929.0623.84
Price / Sales2.076,881.75475.7513.38
Price / Cash4.1313.1327.6282.69
Price / Book1.3178.489.714.48
Net IncomeC$3.39M-C$96.07MC$3.55BC$300.68M
7 Day PerformanceN/A0.61%1.65%0.12%
1 Month Performance11.11%3.71%5.54%2.88%
1 Year Performance-36.71%48.00%34.16%57.88%

Microbix Biosystems Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBX
Microbix Biosystems
N/AC$0.25
-2.0%		N/AN/AC$34.64MC$16.76MN/AN/A
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%		N/AN/AC$102.38MN/AN/AN/A
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/AN/AN/A
NVH
Novoheart
N/AC$0.53
+1.9%		N/AN/AC$99.98MC$423.50KN/AN/A
IGX
IntelGenx Technologies
N/AC$0.58
+1.8%		N/AN/AC$87.32MC$1.75MN/A2,050

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:MBX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel